Helicobacter pylori strain MSL190

Helicobacter pylori strain MSL190 is a microaerophilic, Gram-negative bacterium characterized by its spirilla shape and single-cell arrangement. This strain is notable for its presence in a variety of hosts, including Homo sapiens, Gallus gallus, Aves, Primates, Mammalia, Amoeba, Rodentia, Cricetinae, and Thais. It possesses flagella, which contribute to its motility, although it is categorized as non-motile. MSL190 thrives at an optimal temperature of 37°C, indicating its mesophilic nature. This strain is associated with numerous significant health effects, predominantly related to the gastrointestinal system. It is implicated in chronic gastric inflammation, peptic ulcer disease, and various forms of gastric cancer, including adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. Other health issues linked to MSL190 include GERD, chronic gastritis, and dyspepsia. The pathogenicity of this strain in humans highlights its potential to induce serious gastrointestinal diseases, which can lead to chronic conditions such as atrophic gastritis and intestinal metaplasia. Biologically, Helicobacter pylori strain MSL190 exemplifies a free-living organism that can inhabit the gastric mucosa of its hosts. Its ability to thrive in the acidic environment of the stomach while contributing to various disease processes underscores the complex interplay between host physiology and microbial pathogenicity. Understanding the traits and health effects associated with MSL190 can inform treatment approaches for conditions linked to this bacterium, emphasizing the importance of managing infection to prevent serious health outcomes.